182
Participants
Start Date
March 15, 2023
Primary Completion Date
June 20, 2024
Study Completion Date
June 1, 2026
Tobemstomig
Participants will receive intravenous (IV) tobemstomig for four 21-day cycles
Pembrolizumab
Participants will receive IV pembrolizumab four 21-day cycles
Paclitaxel
Participants will receive IV paclitaxel Q3W for four 21-day cycles
Pemetrexed
Participants will receive IV pemetrexed Q3W until disease progression or unacceptable toxicity
Carboplatin
Participants will receive IV carboplatin Q3W for four 21-day cycles
UZ Brussel, Brussels
Westmead Hospital, Westmead
AZ St Maarten Campus Leopoldstr, Mechelen
UZ Leuven Gasthuisberg, Leuven
Monash Health, Melbourne
Barwon Health, Geelong
Jessa Zkh (Campus Virga Jesse), Hasselt
Lyell McEwin Hospital, Adelaide
Instituto Nacional de Cancerologia, Distrito Federal
Complejo Hospitalario Universitario A Coruña (CHUAC), A Coruña
IRCCS AOU San Martino - IST, Genoa
Irccs Istituto Europeo di Oncologia (IEO), Milan
Asst Di Monza, Monza
Trakya Universitesi Tip Fakultesi, Medikal Onkoloji Bilim Dali, Balkan Yerleskesi, Edirne
LungenClinic Großhansdorf GmbH, Großhansdorf
Hospital Universitario 12 de Octubre, Madrid
Hospital Regional Universitario Carlos Haya, Málaga
CHU de Toulouse - Hôpital Larrey, Toulouse
Medipol University Medical Faculty, Istanbul
Lungenfachklinik Immenhausen, Immenhausen
IOV - Istituto Oncologico Veneto - IRCCS, Padua
?zmir Medical Park, Izm?r
AZ.Osp S. Orsola ? Malpighi-Reparto di Oncologia Medica, Bologna
Ico Rene Gauducheau, Saint-Herblain
Uniklinik Essen, Essen
Pusan National University Hospital, Busan
Centre Leon Berard, Lyon
Thoraxklinik Heidelberg gGmbH, Heidelberg
Hopital Cochin, Paris
Azienda Ospedaliera San Giuseppe Moscati, Avellino
Henry Ford Health System, Detroit
Renown Regional Medical Center Hospital, Reno
Crio - Centro Regional Integrado de Oncologia, Fortaleza
Nucleo de Oncologia da Bahia - NOB, Salvador, Bahia
Hospital Nossa Senhora da Conceicao, Porto Alegre
Hospital de Clínicas de Porto Alegre X, Porto Alegre
Hospital de Cancer de Barretos, Barretos
Instituto do Cancer do Estado de Sao Paulo - ICESP, São Paulo
Krankenhaus Martha-Maria Halle-Doelau, Halle
"Policlinico Universitario Agostino Gemelli", Rome
ONCARE Viaducto Napoles, Mexico City
AMIISTO Atencion Medica Integral Investigacion y Terapia Oncologica S.A de C.V, Mexico City
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Korea University Guro Hospital, Seoul
Hospital Son Llatzer, Palma de Mallorca
Institut Catala d Oncologia Hospitalet, L'Hospitalet de Llobregat
Hospital Universitari Vall d'Hebron, Barcelona
Memorial Ankara Hastanesi, Ankara
Ankara City Hospital, Ankara
Hoffmann-La Roche
INDUSTRY